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Abstract This commentary discusses our current understand-
ing about Strongyloides stercoralis prevalence rates in the
United States (USA) in the context of healthcare delivery to
immigrants from Latin America. A literature search reveals
that while prevalence rates in Latin American countries are
not well documented, the rates in Latin American immigrants
living in the USA are even less well known. This limited un-
derstanding compounds the health challenge facing immi-
grants who already have limited access to the healthcare sys-
tem. To better address this problem, we suggest improved par-
asitological screening plus additional funding for free clinics.
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Introduction
Large migratory waves have always shaped the ethnic com-
position of the United States (USA). In particular, the past
50 years have been characterized by a steady stream of immi-
grants from Latin America, making individuals of Hispanic/
Latino origin the largest group of foreign-born in this country.
Institutions which provide healthcare services to immigrant
groups need to be aware of the possible endemic conditions
present in this population in order to provide adequate care
and anticipate future needs.
There are almost 12 million unauthorized migrants current-
ly living in the USA, of which 8.1 million (71 %) originated in
Mexico and Central American countries, where gastrointesti-
nal parasites are endemic due to inadequate sanitary condi-
tions [1]. Unauthorized immigrants bypass the mandatedmed-
ical examination that US immigration authorities impose on
those who petition their residency. While all other immigrants
who petition for legal residence in the USA must undergo
some form of medical examination, only refugees receive
treatment for presumptive strongyloidiasis, schistosomiasis,
and soil-transmitted helminths (STH) [2].
This is of particular concern when we consider
Strongyloides stercoralis, a nematode generally classified sep-
arately from the group of STH composed by Ascaris
lumbricoides, Trichuris trichiura, Necator americanus, and
Ancylostoma duodenale [3].
S. stercoralis causes a gastrointestinal infection that has
several distinctive features. First, S. stercoralis can cause a
lifelong infection due to its capability to re-infect its human
host. This infection can become life-threatening under some
conditions. Second, laboratory tests to diagnose most STH are
not sensitive enough to reliably detect S. stercoralis due to its
low larval content in stool. Third, S. stercoralis prevalence in
Latin American countries is incomplete. Finally, the anti-
helminthic drugs most frequently used in STH deworming
campaigns in the region (albendazole and mebendazole) are
highly effective against STHs, but they are not the preferred
drugs for S. stercoralis.
In this commentary, we will focus on S. stercoralis preva-
lence in Central America, particularly in Mexico, Guatemala,
El Salvador, and Honduras, because these are the top
four Latin American countries of origin for unauthorized
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We will also analyze prevalence data from Latin American
immigrants currently living in the USA. Though this article is
not an exhaustive review on this topic, our intention is to
emphasize what we know about S. stercoralis prevalence rates
to the medical community providing health services to immi-
grant groups. To that end, we also discuss the medical capa-
bilities of two large charity healthcare organizations serving
predominantly Hispanic/Latino immigrants in the
Washington, DC metropolitan area.
Strongyloidiasis Prevalence in the Americas
We consulted epidemiological information made available by
the Pan-American Health Organization (PAHO). PAHO plays
a significant role in the systematic surveillance, design, and
execution of deworming campaigns targeting STHs in the
region. However, these surveillance programs have not in-
cluded, so far, an assessment of S. stercoralis epidemiology.
According to PAHO executive staff, efforts are currently un-
derway to design and implement a much-needed systematic
and standardized surveillance of S. stercoralis prevalence. In
their literature review from July 2013, Schär and colleagues
summarized the results of independent, Latin American-based
studies investigating S. stercoralis prevalence rates. The au-
thors note significant variations in the available data based on
the type of study they found (e.g., community-based vs.
hospital-based studies) as well as on the different sensitivity
(low, medium, or high) of the diagnostic methods [3–5].
As an example, some S. stercoralis prevalence rates for
selected countries are Mexico (1.6 and 5.7 %), Guatemala
(unavailable and 2 %), and Honduras (3.2 and 29.8 %) for
community-based and hospital-based studies, respectively
[3]. Those values include diagnostic methods with different
sensitivities. No data was available for El Salvador.
Collectively, this prevalence data show how difficult
it would be to estimate S. stercoralis health risk in this
sub-group of Latin American countries with the information
that is currently available and underscores the need for a
systematic surveillance approach.
Looking at the S. stercoralis data currently available on
foreign-born individuals living in the USA, the Centers for
Disease Control and Prevention (CDC) report a prevalence
range between 0 and 46.1 % [6]. This wide range comprises
data obtained from different international immigrant groups.
Values on the upper end of this range correspond to studies
investigating refugee groups from Africa and Asia (e.g., 46 %
prevalence in a group of Sudanese refugees) [7].
We searched for S. stercoralis prevalence rates, limiting the
query to studies performed in the USA between 1990 and
2015 on subjects born in Latin America who are not immu-
nocompromised, and found only four studies. However, only
two of these studies were performed in healthy individuals
while the other two investigated S. stercoralis in patients with
a medical condition [8–11] (Table 1).
Clearly, prevalence values ranging from 4.6 to 10.5 % are
on the lower end of the ones reported by the CDC. Recent S.
stercoralis prevalence data obtained by our group also falls
within this range (unpublished data). It is not known whether
patients included in these studies were subjected to presump-
tive deworming treatments in their country of origin or in the
USA that could have reduced the proportion of positive cases
detected. Future studies controlling this variable are needed.
From this data, we conclude that while it may not be pos-
sible to accurately estimate the S. stercoralis health risk in
Latin American immigrants, limited surveillance studies per-
formed in the USA seem to indicate prevalence values be-
tween 5.0 and 10.0 %. Although actual S. stercoralis preva-
lence needs to be refined, this information can still be useful to
medical service providers.
Healthcare Options for the New and Undocumented
Immigrant
In the USA, recent documented and undocumented immi-
grants have limited access to health care. Under the
Affordable Care Act (ACA), immigrants who are lawfully
present in the USAwho do not have employer-provided health
insurance are able to purchase private health insurance
through the government’s marketplaces only after 5 years of
residence in the country [12].
The vast majority of undocumented immigrants or those
with a legal immigration status but who don’t have health
insurance are forced to seek care through emergency rooms,
federally qualified health centers (FQHC), and charity-
supported free clinics, with the exception of a small number
of states that use their own funds to provide Medicaid and
Children’s Health Insurance Program (CHIP) coverage.
Table 1 S. stercoralis prevalence studies performed in the USA on
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We interviewed administrative officers at two large primary
care organizations that provide medical services in the
Washington, DC metropolitan area to a population that is pre-
dominantly uninsured or below the federal poverty line.
Combined, these two organizations provide over 70,000
patient visits per year. Eighty percent of these services are
delivered to uninsured individuals of Hispanic origin.
In 2014, the smaller of these two organizations provided
medical care worth 4.7 million US dollars to individuals who
were unable to pay for medical services.
Maria Gomez, the president and CEO of Mary’s Center, a
FQHC in Washington, DC stressed that these clinics deliver
much-needed primary care in response to top medical con-
cerns in the adult and pediatric populations they serve.
Services focus on frequently observed conditions such as obe-
sity, hypertension, diabetes, prenatal care, and several com-
mon pediatric concerns. However, these two healthcare orga-
nizations stated that they are not able to offer routine parasi-
tological screening to their patients due to the high cost of
laboratory tests. One clinic admitted that specific parasitolog-
ical training would be beneficial to increase awareness in their
team of primary care practitioners (doctors and nurses).
Unfortunately, S. stercoralis infection can have fairly unspe-
cific symptoms and practitioners may not consider this
presumptive diagnosis initially.
Conclusion
Our current understanding of S. stercoralis infection preva-
lence rates in Latin American immigrants in the USA is
affected by the following factors:
1. Lack of standardized prevalence data available from
countries in the Latin American region
2. Very limited number of studies documenting S. stercoralis
prevalence rates in Latin American immigrants living in
the USA
3. Limited healthcare accessibility for immigrants: generally
limited to primary care, which may be affected by cost
restrictions on diagnostic services for gastrointestinal par-
asitic infections
Given the current global landscape, it is critical that we are
prepared to identify and treat patients with neglected parasitic
infections (NPI) coming to the USA from different parts of the
world. We should consider the systematic screening of para-
sitic diseases by immigration authorities at borders and
community-based screening in areas with high immigrant
density. For clinics that are already providing health care to
vulnerable populations, additional funding is needed to cope
with an increased number of patients and complexity of
services.
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